https://www.bioworld.com/rss en-us Escherichia coli and Klebsiella pneumoniae, to treat urinary tract infections, pneumonia and bloodstream infections.]]> http://www.bioworld.com/articles/729371 Thu, 05 Mar 2026 08:00:00 -0500 https://www.bioworld.com/articles/729371-carb-x-supports-antibiotic-development-at-harvard Petri dish New England Journal of Medicine.]]> http://www.bioworld.com/articles/729101 Fri, 20 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/729101-bioversys-tuberculosis-combo-targets-drug-resistance Tuberculosis http://www.bioworld.com/articles/728937 Thu, 19 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728937-stoked-bio-licenses-rights-to-enterololin-for-crohns-disease Colorized scanning electron micrograph of E. coli bacteria. Escherichia coli bacteria. Credit: National Institute of Allergy and Infectious Diseases, NIH http://www.bioworld.com/articles/726975 Fri, 12 Dec 2025 12:00:00 -0500 https://www.bioworld.com/articles/726975-nuzolvence-blujepa-win-fda-nods-for-gonorrhea Illustration of Neisseria gonorrhoeae http://www.bioworld.com/articles/726622 Tue, 02 Dec 2025 12:00:00 -0500 https://www.bioworld.com/articles/726622-subcutaneous-biologics-maker-bao-pharma-prices-128m-ipo http://www.bioworld.com/articles/725248 Thu, 16 Oct 2025 09:00:00 -0400 https://www.bioworld.com/articles/725248-novel-antibiotic-based-on-dimethylcysteamine-pleuromutilin Colorized scanning electron micrograph of MRSA. Methicillin-resistant Staphylococcus aureus bacteria (yellow) and a dead human white blood cell (colored red.) Credit: National Institute of Allergy and Infectious Diseases, NIH http://www.bioworld.com/articles/721014 Wed, 11 Jun 2025 11:00:00 -0400 https://www.bioworld.com/articles/721014-us-drug-security-will-come-at-a-price Blister drug pack atop globe Enterobacterales.]]> http://www.bioworld.com/articles/718935 Fri, 04 Apr 2025 09:00:00 -0400 https://www.bioworld.com/articles/718935-arrepaths-antibiotic-targeting-enterobacterales-receives-carb-x-funding Enterobacteriaceae http://www.bioworld.com/articles/718615 Tue, 25 Mar 2025 15:15:00 -0400 https://www.bioworld.com/articles/718615-fda-clears-new-class-of-antibiotic-with-nod-for-gsks-blujepa Acinetobacter baumannii (CRAB) infection with novel antibacterial drug Xacduro (sulbactam-durlobactam). Through the collaboration, Zai Lab will leverage Pfizer’s commercial infrastructure in the anti-infective space to widen access to Xacduro in mainland China. Terms of the deal were not released.]]> http://www.bioworld.com/articles/714901 Tue, 26 Nov 2024 00:00:00 -0500 https://www.bioworld.com/articles/714901-zai-lab-pfizer-team-up-to-widen-china-access-to-antibacterial-xacduro China U.S. handshake Acinetobacter baumannii (CRAB) infection with novel antibacterial drug Xacduro (sulbactam-durlobactam). Through the collaboration, Zai Lab will leverage Pfizer’s commercial infrastructure in the anti-infective space to widen access to Xacduro in mainland China. Terms of the deal were not released.]]> http://www.bioworld.com/articles/714648 Fri, 22 Nov 2024 00:00:00 -0500 https://www.bioworld.com/articles/714648-zai-lab-pfizer-team-up-to-widen-china-access-to-antibacterial-xacduro China U.S. handshake http://www.bioworld.com/articles/713932 Fri, 25 Oct 2024 14:00:00 -0400 https://www.bioworld.com/articles/713932-with-fda-approval-iterums-patience-pays-off http://www.bioworld.com/articles/713601 Thu, 17 Oct 2024 12:00:00 -0400 https://www.bioworld.com/articles/713601-avoiding-losses-results-in-insider-trading-settlement http://www.bioworld.com/articles/709102 Mon, 03 Jun 2024 09:00:00 -0400 https://www.bioworld.com/articles/709102-new-antibiotic-smartly-kills-the-bad-guys-but-spares-the-good-ones Illustration comparing cell walls of gram-positive and gram-negative bacteria http://www.bioworld.com/articles/708477 Fri, 10 May 2024 12:00:00 -0400 https://www.bioworld.com/articles/708477-uk-expands-subscription-model-on-antibiotic-pilot-program-success Capsules in blister packs http://www.bioworld.com/articles/707554 Mon, 15 Apr 2024 09:00:00 -0400 https://www.bioworld.com/articles/707554-preclinical-characterization-of-new-triaromatic-pleuromutilin-antibiotic-candidate Staphylococcus aureus bacteremia, acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia.]]> http://www.bioworld.com/articles/707281 Thu, 04 Apr 2024 12:00:00 -0400 https://www.bioworld.com/articles/707281-us-fda-approves-antibiotic-zevtera-basilea-seeks-us-partner Staphylococcus aureus http://www.bioworld.com/articles/707034 Tue, 26 Mar 2024 12:00:00 -0400 https://www.bioworld.com/articles/707034-emas-chmp-backs-new-antibiotic-oral-pnh-drug-in-march-meeting EU flag, pills, syringe http://www.bioworld.com/articles/706953 Fri, 22 Mar 2024 12:00:00 -0400 https://www.bioworld.com/articles/706953-emas-chmp-backs-new-antibiotic-oral-pnh-drug-in-march-meeting EU flag, pills, syringe http://www.bioworld.com/articles/706101 Mon, 26 Feb 2024 12:00:00 -0500 https://www.bioworld.com/articles/706101-gsks-oral-antibiotic-hits-endpoints-in-gonorrhea-study http://www.bioworld.com/articles/706029 Fri, 23 Feb 2024 12:00:00 -0500 https://www.bioworld.com/articles/706029-fda-issues-crl-for-venatorxs-antibiotic-combo-in-utis Bladder, urinary tract illustration with bacteria http://www.bioworld.com/articles/704924 Wed, 24 Jan 2024 12:00:00 -0500 https://www.bioworld.com/articles/704924-uk-further-restricts-use-of-fluoroquinolones Acinetobacter baumannii. The most advanced member of the class, zosurabalpin (RG-6006, Roche AG), was effective against multiple A. baumannii strains, including carbapenem-resistant and multidrug-resistant strains.]]> http://www.bioworld.com/articles/704312 Thu, 04 Jan 2024 09:00:55 -0500 https://www.bioworld.com/articles/704312-old-fashioned-screening-approach-yields-new-antibiotic-class Acinetobacter spp. A 3D computer-generated image of a group of multidrug-resistant Acinetobacter spp. bacteria. The artistic recreation was based upon scanning electron microscopic imagery. Credit: CDC/Antibiotic Resistance Coordination and Strategy Unit; James Archer, medical illustrator Nature on Dec. 20, 2023. In animal testing, compounds identified via the method showed that they had activity against drug-resistant gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA), one of the most serious bacterial public health threats.]]> http://www.bioworld.com/articles/703901 Wed, 20 Dec 2023 09:00:00 -0500 https://www.bioworld.com/articles/703901-explainable-ai-finds-new-class-of-antibiotics Bacteria targeted by technology concept art Using a type of artificial intelligence known as deep learning, MIT researchers have discovered a class of compounds that can kill a drug-resistant bacterium that causes more than 10,000 deaths in the U.S. every year. Credit: Christine Daniloff, MIT; Janice Haney Carr, CDC; iStock Staphylococcus aureus strains resistant to almost all approved antibiotics in the clinic poses an urgent public health concern. Thus, new antibiotics exploiting alternative antibacterial mechanisms or molecular structures are critically needed to address the long-term threat of multidrug-resistant S. aureus, particularly methicillin-resistant S. aureus (MRSA).]]> http://www.bioworld.com/articles/703702 Wed, 13 Dec 2023 09:00:00 -0500 https://www.bioworld.com/articles/703702-new-dapg-derivatives-acting-on-bacterial-cell-membranes-hold-promise-to-treat-mrsa-infections Colorized scanning electron micrograph of MRSA. Methicillin-resistant Staphylococcus aureus bacteria (yellow) and a dead human white blood cell (colored red.) Credit: National Institute of Allergy and Infectious Diseases, NIH http://www.bioworld.com/articles/700277 Wed, 23 Aug 2023 09:00:00 -0400 https://www.bioworld.com/articles/700277-cage-fight-could-make-for-resistance-resistant-antibiotic Clovibactin art concept Clovibactin uses an unsual cage-like binding motif to tightly wrap around pyrophosphate-containing lipids in bacterial cell membranes. Credit: Markus Weingarth, Utrecht University http://www.bioworld.com/articles/699821 Thu, 10 Aug 2023 09:00:00 -0400 https://www.bioworld.com/articles/699821-improved-lpxc-inhibitor-antibiotic-ready-for-human-trials BioWorld.]]> http://www.bioworld.com/articles/698894 Thu, 13 Jul 2023 09:00:00 -0400 https://www.bioworld.com/articles/698894-synthetic-antibiotics-pack-multiple-punches-against-gram-positive-bacteria Acinetobacter baumannii, in adults.]]> http://www.bioworld.com/articles/697353 Wed, 24 May 2023 11:00:00 -0400 https://www.bioworld.com/articles/697353-entasis-bacterial-infection-drug-receives-fda-approval Xacduro Staphylococcus aureus infection on all fronts.In their experiments, which were published in Cell Host & Microbe on April 24, 2023, the team described mAbtyrin, as “a protein-based therapeutic that targets 10 disease-causing mechanisms employed by S. aureus,” senior author Victor Torres told BioWorld. ]]> http://www.bioworld.com/articles/696422 Wed, 26 Apr 2023 09:00:00 -0400 https://www.bioworld.com/articles/696422-for-fighting-staph-infections-multitasking-fusion-protein-is-perfect-10 Colorized scanning electron micrograph of MRSA. Methicillin-resistant Staphylococcus aureus bacteria (yellow) and a dead human white blood cell (colored red.) Credit: National Institute of Allergy and Infectious Diseases, NIH